ReviewAdvances in experimental medicine and biology2025
Formation of Circular RNAs.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) constitute a class of covalently closed, single-stranded RNA molecules that form a continuous loop structure, setting them apart from linear RNA molecules. These circular entities arise through a distinct biogenetic process termed "backsplicing," which involves the covalent bonding of the 5' site of an upstream exon with the 3' site of the same or a downstream exon during pre-messenger RNA (pre-mRNA) splicing. Such a direct backsplicing model exists along with the exon- and lariat-skipping models of circRNA generation, giving rise to three major types of circRNAs, i.e., exonic (EcircRNAs), intronic (IcircRNAs), and exonic-intronic circRNAs (EIcircRNAs). A complex process of interaction between cis-acting elements and trans-acting factors governs circRNA synthesis. In particular, reverse complementary matches (RCMs) and RNA-binding proteins (RBPs) play critical roles in circRNA formation. Complementary sequences increase base pairing, which aids in the alignment of splice sites for backsplicing. RBPs can either accelerate or inhibit circRNA synthesis by binding to certain sequences or structures, thereby altering backsplicing efficiency. The careful balance of cis-acting components and trans-acting factors highlights the complex regulatory mechanisms driving circRNA synthesis, which contributes to the variety and functional relevance of these transcripts in cellular activities. In this chapter, we review the variables that influence circRNA biogenesis and highlight the origins of different types of these transcripts in humans.
Indexed as
Identifiers
40886272What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.